Von dem Buch Real Options and Intellectual Property haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Philipp N. Baecker: Real Options and Intellectual Property (ISBN: 9783540482642) 2007, Springer, Berlin/Heidelberg, Deutschland, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
82%: Philipp N Baecker: Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection (ISBN: 9783540482635) 2007, 2007. Ausgabe, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
Real Options and Intellectual Property - 16 Angebote vergleichen
| Preise | 2013 | 2014 | 2018 | 2019 |
|---|---|---|---|---|
| Schnitt | € 60,75 | € 71,92 | € 100,32 | € 94,44 |
| Nachfrage |
1
Real Options and Intellectual Property (2007)
~EN NW EBISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer, neu, E-Book.
Lieferung aus: Schweiz, Sofort per Download lieferbar.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and, This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. The text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. PDF, 06.08.2007.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and, This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. The text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. PDF, 06.08.2007.
2
Real Options and Intellectual Property (2007)
~EN NW EBISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer, neu, E-Book.
Lieferung aus: Schweiz, Sofort per Download lieferbar.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and, Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. TOC:Introduction.- Patenting Under Uncertainty: Patent Protection, the Firm, and the Economy.- Uncertainty, Irreversibility, and Flexibility.- Patent Protection in the Parmaceutical Industry.- Exogenous Patent Risk: Introduction and Related Work.- Patents as Investment Opportunities.- Patent Risk as Jumps in the Underlying Process.- From Business Shifts to Jump Processes.- Preliminary Conclusion.- Endogenous Patent Risk: Introduction and Related Work.- Patent Risk as an Option to Litigate.- Preliminary Conclusion.- Conclusion.- Appendices. PDF, 06.08.2007.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and, Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. TOC:Introduction.- Patenting Under Uncertainty: Patent Protection, the Firm, and the Economy.- Uncertainty, Irreversibility, and Flexibility.- Patent Protection in the Parmaceutical Industry.- Exogenous Patent Risk: Introduction and Related Work.- Patents as Investment Opportunities.- Patent Risk as Jumps in the Underlying Process.- From Business Shifts to Jump Processes.- Preliminary Conclusion.- Endogenous Patent Risk: Introduction and Related Work.- Patent Risk as an Option to Litigate.- Preliminary Conclusion.- Conclusion.- Appendices. PDF, 06.08.2007.
3
Real Options and Intellectual Property (2007)
~EN NW EBISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer, neu, E-Book.
Lieferung aus: Deutschland, Sofort per Download lieferbar.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. TOC:Introduction.- Patenting Under Uncertainty: Patent Protection, the Firm, and the Economy.- Uncertainty, Irreversibility, and Flexibility.- Patent Protection in the Parmaceutical Industry.- Exogenous Patent Risk: Introduction and Related Work.- Patents as Investment Opportunities.- Patent Risk as Jumps in the Underlying Process.- From Business Shifts to Jump Processes.- Preliminary Conclusion.- Endogenous Patent Risk: Introduction and Related Work.- Patent Risk as an Option to Litigate.- Preliminary Conclusion.- Conclusion.- Appendices. 06.08.2007, PDF.
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. TOC:Introduction.- Patenting Under Uncertainty: Patent Protection, the Firm, and the Economy.- Uncertainty, Irreversibility, and Flexibility.- Patent Protection in the Parmaceutical Industry.- Exogenous Patent Risk: Introduction and Related Work.- Patents as Investment Opportunities.- Patent Risk as Jumps in the Underlying Process.- From Business Shifts to Jump Processes.- Preliminary Conclusion.- Endogenous Patent Risk: Introduction and Related Work.- Patent Risk as an Option to Litigate.- Preliminary Conclusion.- Conclusion.- Appendices. 06.08.2007, PDF.
4
Real Options and Intellectual Property (2007)
~EN PB NWISBN: 9783540482635 bzw. 3540482636, vermutlich in Englisch, Springer, Taschenbuch, neu.
Lieferung aus: Schweiz, Versandfertig innert 4 - 7 Werktagen.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
| Real Options and Intellectual Property | Springer | 2007
~EN NWISBN: 9783540482635 bzw. 3540482636, vermutlich in Englisch, Springer, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
Real Options and Intellectual Property
~EN PB NWISBN: 9783540482635 bzw. 3540482636, vermutlich in Englisch, Springer Shop, Taschenbuch, neu.
Lieferung aus: Deutschland, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Real Options and Intellectual Property (2007)
~EN PB NWISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer-Verlag GmbH, Taschenbuch, neu.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Real Options and Intellectual Property
~EN NW EB DLISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Lagernd.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
9
Real Options and Intellectual Property - Capital Budgeting Under Imperfect Patent Protection
~EN NW EB DLISBN: 9783540482642 bzw. 3540482644, vermutlich in Englisch, Springer Berlin, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…